T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 07/31/2016
Domestic Stock 60.3%
Domestic Bond 21.6%
Cash 9.4%
Foreign Bonds 4.5%
Foreign Stock 3.3%
Convertibles 1.0%
Preferreds 0.9%
Options -0.7%
Volatility and Other Measures
as of 07/31/2016
Beta 0.63
0.93
Standard Deviation 7.13
Price/Earnings Ratio (Domestic) 19.2
Earnings Growth Rate (Domestic) 11.2
Turnover Rate 32
Median Market
Capitalization
$56,237.45 Million
Sector Diversification
as of 07/31/2016
% of Total Net Assets
Health Care 17.9%
Financials 10.7%
Information Technology 9.4%
Consumer Staples 8.5%
Consumer Discretionary 7.6%
Industrials & Business Services 6.4%
Utilities 2.3%
Telecommunication Services 0.7%
Materials 0.6%
Energy 0.5%
10 Largest Holdings
Represents 25.14 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Bank of New York Mellon
Becton, Dickinson & Company
Comcast, Special Class A
Danaher
Marsh & McLennan
Microsoft
PG&E
Thermo Fisher Scientific
As of 07/31/2016 the Capital Appreciation Fund had a total of 289 holdings.
See Glossary for additional details on all data elements.